#ManuscriptMonday In this recent publication, scientists used an Alveolus Lung-Chip to demonstrate how decompression sickness is driven by elevated partial pressures of dissolved gases that cause abnormal immune cell behaviors. See how these findings could have broad implications for high-risk individuals: https://hubs.ly/Q02DWVX90 #research #biotech #organchips
Emulate, Inc.’s Post
More Relevant Posts
-
Our Paper-Based Diagnostics are low-cost, easily deployable and simple-to-use biomolecular devices that can be used in low resource settings around the globe. The devices combine two novel technologies: (1) cell-free synthetic biosensors that can detect the presence of pathogen-derived RNA molecules and that couple detection events to the production of a colored or fluorescent indicator protein, and (2) embedding of the biosensors in paper that can be freeze-dried for long-term storage without refrigeration. #Diagnostics #Sensors #SyntheticBiology #LicensingOpportunity https://lnkd.in/e3qWNMPM
Paper-Based Diagnostics
https://wyss.harvard.edu
-
Small-molecule probe for IBD risk variant GPR65 I231L alters cytokine signaling networks through positive allosteric modulation Science Advances https://lnkd.in/g942rPDs
Small-molecule probe for IBD risk variant GPR65 I231L alters cytokine signaling networks through positive allosteric modulation
science.org
-
Day 21 of #30daysofbiotechinnovation Blood on Demand?! Researchers are Getting Close to Lab-Made Blood! Who knew we'd be talking about lab-grown blood? 🩸 This isn't science fiction anymore! Scientists are making incredible progress in creating blood from stem cells. This could be HUGE for healthcare: No more relying on blood donor availability! Universal blood types on the horizon? Ready Stock: Hospitals could have a constant supply, eliminating critical shortages. Safer Transfusions: Manufactured blood would be free of infectious diseases. Think about the impact this could have on patients needing regular transfusions or those in emergency situations. Biomanufactured blood could be a game-changer! What are your thoughts on this breakthrough? #biotech #futureofmedicine #blooddonations https://lnkd.in/gg8n6Z6q
Biomanufacture of human platelets for transfusion: Rationale and approaches - PubMed
pubmed.ncbi.nlm.nih.gov
-
Recent findings re: commercial immunoassays for identifying pathophysiology can benefit the #ClinicalDevelopment of new #AlzheimersDisease treatments. Read the blog. https://lnkd.in/gYdn-qKK #ClinicalTrials #MedicalImaging #ChooseCalyx
Advances in Alzheimer’s Disease Clinical Trial Screening | Read the blog
calyx.dsmn8.com
-
PharmD Graduate | Clinical Research Professional | Image Research Specialist at Calyx
Recent findings re: commercial immunoassays for identifying pathophysiology can benefit the #ClinicalDevelopment of new #AlzheimersDisease treatments. Read the blog. https://lnkd.in/gkTuQnnj #ClinicalTrials #MedicalImaging #ChooseCalyx
Advances in Alzheimer’s Disease Clinical Trial Screening | Read the blog
calyx.dsmn8.com
-
🔬 #DRL is excited to share new insights into immune tolerance. Researchers have developed synthetically glycosylated antigens to suppress specific immune responses. This innovative approach targets established immune responses in T cells using a polymer conjugated to the antigen, showing promise in treating autoimmune diseases. The study published in Nature Biomedical Engineering demonstrates effective antigen-specific tolerance in mouse models of autoimmune encephalomyelitis and in non-human primates vaccinated against a simian immunodeficiency virus. This breakthrough discovery will revolutionize treatments for autoimmune conditions. Stay tuned for more updates on how new discoveries transform healthcare and drive #HealthcareInnovation! The article can be found here: https://lnkd.in/dWtSQhEM
-
-
Recent findings re: commercial immunoassays for identifying pathophysiology can benefit the #ClinicalDevelopment of new #AlzheimersDisease treatments. Read the blog. https://lnkd.in/geCbXje6 #ClinicalTrials #MedicalImaging #ChooseCalyx
Advances in Alzheimer’s Disease Clinical Trial Screening | Read the blog
calyx.dsmn8.com
-
Recent findings re: commercial immunoassays for identifying pathophysiology can benefit the #ClinicalDevelopment of new #AlzheimersDisease treatments. Read the blog. https://lnkd.in/eFemPZXD #ClinicalTrials #MedicalImaging #ChooseCalyx
Advances in Alzheimer’s Disease Clinical Trial Screening | Read the blog
calyx.dsmn8.com
-
Recent findings re: commercial immunoassays for identifying pathophysiology can benefit the #ClinicalDevelopment of new #AlzheimersDisease treatments. Read the blog. https://lnkd.in/gqEGzr62 #ClinicalTrials #MedicalImaging #ChooseCalyx
Advances in Alzheimer’s Disease Clinical Trial Screening | Read the blog
calyx.dsmn8.com
